Earnings Feed
Start Free
Home/Insiders/Advent Life Sciences LLP
AL
SEC Insider//CIK 0001601364

Advent Life Sciences LLP

CIK 00016013642 companiesLONDON, X0
SEC Profile

Transactions

23

Companies

2

Filings

4

CIK

0001601364

Recent Transactions

23 trades
  • Conversion
    Axonics, Inc.

    Common Stock

    2018-11-02+43,822→ 43,822 total
  • Conversion
    Axonics, Inc.

    Common Stock

    2018-11-02+1,231,178→ 1,275,000 total
  • Conversion
    Axonics, Inc.

    Common Stock

    2018-11-02+14,412→ 1,289,412 total
  • Conversion
    Axonics, Inc.

    Common Stock

    2018-11-02+404,937→ 1,694,349 total
  • Conversion
    Axonics, Inc.

    Series B-2 Preferred Stock

    2018-11-02−36,518→ 0 total
  • Conversion
    Axonics, Inc.

    Series B-2 Preferred Stock

    2018-11-02−1,025,981→ 0 total
  • Conversion
    Axonics, Inc.

    Series C Preferred Stock

    2018-11-02−337,447→ 0 total
  • Conversion
    Axonics, Inc.

    Series C Preferred Stock

    2018-11-02−12,010→ 0 total
  • Purchase
    Aravive, Inc.

    Common Stock

    2015-01-22$17.25/sh+55,000→ 2,271,558 total
  • Purchase
    Aravive, Inc.

    Common Stock

    2015-01-22$17.25/sh+55,000→ 2,271,558 total
  • Conversion
    Aravive, Inc.

    Common Stock

    2014-03-26+1,258,086→ 1,258,086 total
  • Conversion
    Aravive, Inc.

    Common Stock

    2014-03-26+489,253→ 1,747,339 total
  • Conversion
    Aravive, Inc.

    Common Stock

    2014-03-26+176,813→ 1,924,152 total
  • Conversion
    Aravive, Inc.

    Common Stock

    2014-03-26+78,228→ 2,002,380 total
  • Conversion
    Aravive, Inc.

    Common Stock

    2014-03-26+154,178→ 2,156,558 total
  • Purchase
    Aravive, Inc.

    Common Stock

    2014-03-26$21.00/sh+60,000→ 2,216,558 total
  • Exercise of In-Money
    Aravive, Inc.

    Warrants to Purchase Series B Preferred Stock

    2014-03-26−506,376→ 0 total
  • Exercise of In-Money
    Aravive, Inc.

    Series B Convertible Preferred Stock

    2014-03-26+506,376→ 14,468,020 total
  • Conversion
    Aravive, Inc.

    Series B Convertible Preferred Stock

    2014-03-26−14,468,020→ 0 total
  • Conversion
    Aravive, Inc.

    Series C Convertible Preferred Stock

    2014-03-26−5,626,413→ 0 total
  • Conversion
    Aravive, Inc.

    Series D-1 Convertible Preferred Stock

    2014-03-26−2,033,350→ 0 total
  • Conversion
    Aravive, Inc.

    Series D-2 Convertible Preferred Stock

    2014-03-26−899,619→ 0 total
  • Conversion
    Aravive, Inc.

    Series E Convertible Preferred Stock

    2014-03-26−1,773,049→ 0 total

Companies

2

Recent Filings

4

Address

158 NORTH GOWER STREET

LONDON, X0, NW1 2ND

View on SEC.gov